MannKind Corporation (MNKD)
NASDAQ·Healthcare·Biotechnology
$2.80
+6.27%
Mkt Cap $833.75M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $97.58M | $111.95M | +14.74% | -$0.01 | -$0.05 | -400.00% | — | — |
| Q4 2025 Nov 5, 2025 | $99.85M | $82.13M | -17.75% | $0.01 | $0.03 | +200.00% | — | — |
| Q3 2025 Aug 6, 2025 | $80.16M | $76.53M | -4.53% | $0.04 | $0.00 | -94.65% | — | — |
| Q2 2025 May 8, 2025 | $78.44M | $78.35M | -0.11% | $0.03 | $0.04 | +33.33% | — | — |
| Q1 2025 Feb 26, 2025 | $74.98M | $76.78M | +2.40% | $0.03 | $0.03 | +0.00% | — | — |
| Q4 2024 Nov 7, 2024 | $74.87M | $70.08M | -6.40% | $0.06 | $0.04 | -33.33% | — | — |
| Q3 2024 Aug 7, 2024 | $64.81M | $72.39M | +11.69% | -$0.03 | $0.05 | +249.93% | — | — |
| Q2 2024 May 8, 2024 | $60.49M | $66.26M | +9.54% | $0.03 | $0.04 | +53.85% | — | — |
| Q1 2024 Feb 27, 2024 | $53.58M | $58.47M | +9.13% | — | $0.02 | — | — | — |
| Q4 2023 Nov 7, 2023 | $50.72M | $51.25M | +1.05% | $0.01 | $0.02 | +160.76% | — | — |
| Q3 2023 Aug 7, 2023 | $42.95M | $48.61M | +13.18% | -$0.01 | -$0.02 | -47.38% | — | — |
| Q2 2023 May 9, 2023 | $37.40M | $40.63M | +8.63% | -$0.05 | -$0.04 | +20.00% | — | — |
| Q1 2023 Feb 23, 2023 | $35.50M | $36.06M | +1.57% | -$0.06 | -$0.07 | -16.67% | — | — |
| Q4 2022 Nov 8, 2022 | $25.49M | $32.83M | +28.80% | -$0.10 | -$0.06 | +40.00% | — | — |
| Q3 2022 Aug 9, 2022 | $15.62M | $18.89M | +20.93% | -$0.09 | -$0.11 | -22.22% | — | — |
| Q2 2022 May 5, 2022 | $10.58M | $11.99M | +13.33% | -$0.10 | -$0.10 | +0.00% | — | — |
| Q1 2022 Feb 24, 2022 | $17.07M | $12.52M | -26.70% | -$0.06 | -$0.11 | -83.33% | — | — |
| Q4 2021 Nov 9, 2021 | $20.62M | $22.21M | +7.72% | -$0.05 | -$0.04 | +20.00% | — | — |
| Q3 2021 Aug 11, 2021 | $17.49M | $23.28M | +33.10% | -$0.04 | -$0.05 | -25.00% | — | — |
| Q2 2021 May 12, 2021 | $13.08M | $17.44M | +33.33% | -$0.04 | -$0.05 | -17.65% | — | — |